Also announced at ASCO was some intriguing new data on circulating tumour DNA (ctDNA) – fragments of genetic material from cancer cells – that can indicate the presence of minimal residual ...

including recently the Hilton hotel chain. It provides members with primary and preventive care, ongoing support for chronic conditions, and referrals to secondary and tertiary care, as well as ...

presented at the American Society of Clinical Oncology conference (ASCO) in June 2024. Additional data from Phase 2a study of single agent BI-1808 are expected by mid-2025. BioInvent International ...

2025 at the The Roosevelt Hotel in New Orleans. Mr. Lazarus’s presentation will provide an overview of Pasithea’s next generation macrocyclic MEK inihibitor, PAS-004, including interim safety, ...

*During data validation and verification for the manuscript, one patient that was originally reported as having a response in the 2021 AACR Annual Meeting presentation of this cohort was found instead ...